StockClub

NMRA

NMRANeumora Therapeutics, Inc. Common Stock$ --
Neumora Therapeutics, Inc. Common Stock

Neumora Therapeutics, Inc. Common Stock

NMRA

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
0M USD
YoY -
Operating Income
-53M USD
YoY +25.5%
Net Income
-53M USD
YoY +21.4%
EPS
-0.3$
YoY +28.6%

Revenue

$0
FY2024 Q2$0
$0
Q2
FY2024 Q3$0
$0
Q3
FY2024 Q4$0
$0
Q4
FY2025 Q1$0
$0
Q1
FY2025 Q2$0
$0
Q2
FY2025 Q3$0
$0
Q3
FY2025 Q4$0
$0
Q4
FY2026 Q1$0
$0
Q1
Actual
$0 (-)

Net Income

$-53.5M
FY2024 Q2$-112.4M
$-112.4M
Q2
FY2024 Q3$-185M
$-185M
Q3
FY2024 Q4$-243.8M
$-243.8M
Q4
FY2025 Q1$-68M
$-68M
Q1
FY2025 Q2$-120.7M
$-120.7M
Q2
FY2025 Q3$-177.5M
$-177.5M
Q3
FY2025 Q4$-236.9M
$-236.9M
Q4
FY2026 Q1$-53.5M
$-53.5M
Q1
Actual
+$14.5M (+21.4%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020
Actual:$0
FY2020
$0
FY2021
Actual:$0
FY2021
$0
FY2022
Actual:$0
FY2022
$0
FY2023
Actual:$0
FY2023
$0
FY2024IN-LINE
Actual:$0
Est:$0
FY2024IN-LINE
$0
FY2025IN-LINE
Actual:$0
Est:$0
FY2025IN-LINE
$0

Analyst Estimates